CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
Income statement
| Line | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $68M | $88M | $18M | $7.5M | $95M | $70M | $56M | $27M | $32M | $13M | $106M | $29M | $47M | $31M | $7.6M | $4.0M | $2.6M | $82M |
| R&D | $397M | $416M | $339M | $330M | $241M | $160M | $97M | $86M | $89M | $90M | $60M | $46M | $44M | $49M | $36M | $37M | $38M | $40M |
| Operating income | −$708M | −$612M | −$536M | −$496M | −$324M | −$186M | −$94M | −$99M | −$89M | −$113M | $19M | −$37M | −$15M | −$34M | −$40M | −$48M | −$50M | $26M |
| Non-operating income | — | — | — | — | — | — | — | — | −$17M | −$14M | −$2.2M | −$94K | $108K | $177K | $87K | $104K | $172K | −$1.4M |
| Pretax income | — | — | — | — | — | — | — | — | −$106M | −$128M | $16M | −$38M | −$15M | −$34M | −$40M | −$48M | −$49M | $25M |
| Taxes | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$176K | $150K |
| Net income | −$894M | −$785M | −$590M | −$526M | −$389M | −$215M | −$127M | −$122M | −$106M | −$128M | $16M | −$38M | −$15M | −$34M | −$40M | −$48M | −$49M | $25M |
| Diluted EPS | −$7.23 | −$6.54 | −$5.26 | −$5.45 | −$4.33 | −$2.80 | −$1.97 | −$2.11 | −$1.95 | −$2.59 | $0.39 | −$0.97 | −$0.41 | −$1.24 | −$2.30 | −$4.32 | −$4.62 | $2.52 |
| Diluted shares | — | 120K | 112K | 97K | 90K | 77K | 65K | 57.6M | 54.4M | 49.4M | 42.6M | 38.8M | 35.7M | 27.3M | 18.1M | 11.8M | 10.7M | 9.7M |
| Revenue growth | — | +376.6% | +145.3% | −92.0% | +34.3% | +26.2% | +107.8% | −14.7% | +135.6% | −87.4% | +271.3% | −38.9% | +53.2% | +305.5% | +89.0% | +55.2% | −96.8% | — |
| Operating margin | −1,046.1% | −695.4% | −2,902.7% | −6,589.7% | −342.8% | −264.5% | −168.3% | −368.0% | −282.3% | −848.3% | 17.6% | −130.5% | −31.4% | −110.6% | −535.2% | −1,199.1% | −1,926.1% | 32.0% |
| Net margin | −1,321.1% | −891.6% | −3,191.1% | −6,988.6% | −411.2% | −305.7% | −228.0% | −452.9% | −337.4% | −955.9% | 15.5% | −130.9% | −31.2% | −110.0% | −534.1% | −1,196.5% | −1,912.6% | 30.1% |
Cost of revenue, other operating expenses, non-operating income and taxes are the differences between the lines reported around them.